Markets:

Overview

News

Currencies

International

Treasuries

Monopar Therapeutics Inc. - Common Stock (NQ:MNPR)

109.96 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EDT, Sep 10, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Monopar Therapeutics Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >

Why BEST Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket ↗

November 06, 2023

Gainers Carbon Revolution Public Limited (NASDAQ: CREV) shares surged 358% to $134.37 in pre-market trading after gaining 100% on Friday. The company’s stock began trading on Friday following merger...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

November 03, 2023

It's time to dive into the biggest pre-market stock movers for Friday with all the shares investors will want to keep an eye on today!

Via InvestorPlace

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

November 01, 2023

Via Benzinga

Where Monopar Therapeutics Stands With Analysts ↗

June 01, 2023

Via Benzinga

Expert Ratings for Monopar Therapeutics ↗

May 15, 2023

Via Benzinga

Why Extreme Networks Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

November 01, 2023

Gainers

Via Benzinga

Why Is Cancer Focused Monopar Therapeutics Stock Trading Higher Today? ↗

November 01, 2023

Monopar Therapeutics Inc (NASDAQ: MNPR) will present data from its ongoing Phase 1b open-label, dose-escalating trial of camsirubicin in patients with advanced soft tissue sarcoma later today at the...

Via Benzinga

US Stocks Mixed; Private Sector Payrolls Increase Less Than Expected ↗

November 01, 2023

U.S. stocks traded mixed this morning, ahead of interest rate decision from the Federal Reserve. Following the market opening Wednesday, the Dow traded down 0.05% to 33,036.63 while the NASDAQ rose...

Via Benzinga

Topics Economy Stocks

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

November 01, 2023

Via Benzinga

Monopar Presents Data Showing Tumor Reduction Benefit of Camsirubicin from Ongoing Phase 1b at the 2023 Connective Tissue Oncology Society (CTOS) Annual Meeting

November 01, 2023

From Monopar Therapeutics Inc.

Via GlobeNewswire

Monopar to Participate in the Roth MKM 2023 Healthcare Opportunities Conference

October 10, 2023

From Monopar Therapeutics Inc.

Via GlobeNewswire

Monopar to Participate in the H.C. Wainwright 25th Annual Global Investment Conference

September 05, 2023

From Monopar Therapeutics Inc.

Via GlobeNewswire

Monopar Therapeutics Reports Second Quarter 2023 Financial Results and Recent Developments

August 10, 2023

From Monopar Therapeutics Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

August 09, 2023

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

August 08, 2023

Via Benzinga

Monopar Provides Encouraging Camsirubicin Clinical Data Update

August 08, 2023

From Monopar Therapeutics Inc.

Via GlobeNewswire

Why BYND Cannasoft Enterprises Shares Are Trading Lower By 40%; Here Are 20 Stocks Moving Premarket ↗

July 17, 2023

Gainers

Via Benzinga

Why Acumen Pharmaceuticals Shares Are Trading Higher By Over 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

July 17, 2023

Gainers ProMIS Neurosciences, Inc. (NASDAQ: PMN) shares jumped 126.6% to $6.37. ProMIS showcased preclinical data at the Alzheimer's Association International Conference 2023 on computationally-derived...

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

July 14, 2023

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

July 14, 2023

Via Benzinga

Why State Street Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

July 14, 2023

Gainers PainReform Ltd. (NASDAQ: PRFX) shares climbed 103% to $11.67. PainReform recently announced pricing of a $2.7 million concurrent registered direct offering and private placement.

Via Benzinga

Monopar Announces MNPR-101 Radiopharma Collaboration Agreement with National University of Singapore

July 11, 2023

From Monopar Therapeutics Inc.

Via GlobeNewswire

Monopar to Participate in the Radiopharma Forum by the Lake 2023

June 21, 2023

From Monopar Therapeutics Inc.

Via GlobeNewswire

Monopar to Participate in the Maxim Group’s Healthcare Virtual Conference

June 14, 2023

From Monopar Therapeutics Inc.

Via GlobeNewswire

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

June 02, 2023

It's time for a dive into the biggest pre-market stock movers for Friday as we check out the winners and losers this morning!

Via InvestorPlace

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

June 01, 2023

Via Benzinga

Monopar Announces Encouraging Camsirubicin Phase 1b Trial Update

June 01, 2023

From Monopar Therapeutics Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

May 30, 2023

Via Benzinga

Monopar Therapeutics Reports First Quarter 2023 Financial Results and Recent Developments

May 11, 2023

Camsirubicin Phase 1b DoseEscalation Trial Enrolling 5th DoseLevel Cohort (650 mg/m2) MNPR-101 RIT Shows Promising Imaging and Therapeutic Preclinical Study Results

From Monopar Therapeutics Inc.

Via GlobeNewswire

Why Nvidia Shares Are Trading Higher By Over 5%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

May 30, 2023

Gainers QualTek Services Inc. (NASDAQ: QTEK) shares jumped 127.2% to $0.1740 after dropping around 21% on Friday. Qualtek Services recently filed voluntarily petitions for Chapter 11 bankruptcy.

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.